TP53 and cancer: We found that the two out of ten (20%) tested cancer-associated mutations (R732C and R1018Q) impair the interaction with 53BP1 and fail to stabilize p53 following mitotic stress, highlighting the importance of this interaction (Fig. 5E, H).